Sign In
Buy ANIX
$2.52
-0.0300 (-1.18%)
At Close: Jun 03, 2026
Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
01:00pm, Monday, 20'th Jul 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that due to public health and safety concerns
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
11:25am, Friday, 10'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9)Affimed NV (NASDAQ: AFMD)Altimmune Inc (NASDAQ: ALT)arge
Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office
11:00am, Friday, 10'th Jul 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that the European Patent Office has issued an
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds
01:00pm, Monday, 06'th Jul 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it and partner OntoChem have completed t
Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline
09:00pm, Thursday, 02'nd Jul 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it has strategically realigned its busin
Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
12:30pm, Monday, 01'st Jun 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that the Company, together with p
Bay Area search for coronavirus drugs extends far beyond remdesivir
12:00pm, Monday, 25'th May 2020
Stanford, Kaiser and others are investigating other drugs that could be repurposed to fight COVID-19. A Silicon Valley company wants to find a new treatment.
Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
10:45am, Monday, 04'th May 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that it, with partner OntoChem Gm
Have Insiders Been Buying Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares?
10:32am, Tuesday, 28'th Apr 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced the publication of a peer-reviewe
San Jose bioscience company launches research into Covid-19 treatment
10:00pm, Tuesday, 21'st Apr 2020
Anixa Biosciences Inc. CEO Amit Kumar told the Business Journal how his company is approaching the search for a Covid-19 treatment differently from other firms.
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics
10:30am, Monday, 20'th Apr 2020
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that it has entered into a strate
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 25.) * Ra Pharmaceuticals Inc (NASDAQ: RARX)Down In The
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
